STEVENS CAPITAL MANAGEMENT LP

Position in LLY — ELI LILLY & Co

CIK 1134813 RADNOR, PA

Position in LLY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$3,297,233

-$6,049,469 QoQ

Shares Held

2,749

-72.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.93%

of 13F equity value

Holder Rank

#2,040

of 4,605 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STEVENS CAPITAL MANAGEMENT LP holds $7,554,742 across 5 Drug Manufacturers - General names. LLY ranks #1 (43.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,749	$3,297,233
2	PFE	Pfizer Inc	85,193	$2,051,447
3	GILD	Gilead Sciences, Inc.	6,346	$801,753
4	JNJ	Johnson & Johnson	3,007	$763,687
5	NVO	Novo Nordisk A S	13,363	$640,622

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,297,233	2,749	-72.9%	Shares	Sole	2026-08-11
2026-03-31	$9,346,702	10,162	+52.3%	Shares	Sole	2026-05-11
2025-12-31	$7,169,190	6,671	-74.3%	Shares	Sole	2026-02-03
2025-09-30	$19,767,041	25,907	+115.2%	Shares	Sole	2025-11-10
2025-03-31	$9,940,652	12,036	+1604.8%	Shares	Sole	2025-05-07
2024-09-30	$625,473	706	-92.6%	Shares	Sole	2024-11-14
2024-03-31	$7,429,518	9,550	+257.1%	Shares	Sole	2024-05-08
2023-09-30	$1,436,285	2,674	+36.4%	Shares	Sole	2023-11-14
2021-09-30	$453,089	1,961	-91.7%	Shares	Sole	2021-11-12
2020-09-30	$3,494,900	23,611	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.